In Vitro Diagnostics Quality Control Market benefits from clinical reforms

The global in vitro diagnostics (IVD) quality control market size was estimated at USD 1.28 billion in 2023 and is projected to reach USD 1.59 billion by 2030, expanding at a CAGR of 3.2% from 2024 to 2030. The rise in the number of certified clinical laboratories offering reliable IVD-based diagnostic services has strengthened patient confidence, which continues to fuel market demand.

Key Market Trends & Insights

  • North America dominated the in vitro diagnostics quality control market with a 47.1% share in 2023.
  • The U.S. accounted for a significant portion of the global market in 2023.
  • By product, the controls segment led the market with a 48.3% share in 2023.
  • By type, the quality controls segment captured the largest revenue share in 2023.
  • By application, the immunochemistry segment held the largest revenue share in 2023.

Market Size & Forecast

  • 2023 Market Size: USD 1.28 Billion
  • 2030 Projected Market Size: USD 1.59 Billion
  • CAGR (2024–2030): 3.2%
  • North America: Largest market in 2023
  • Asia Pacific: Fastest-growing regional market

Some of the key pathogens routinely diagnosed using multiplex PCR include HIV, HSV (meningitis & encephalitis), H. influenza, S. pneumoniae (respiratory infections), N. gonorrhea, C. trachomatis (genital infections), G. lamblia, C. parvum (diarrheal diseases), and Leishmania spp. (Leishmaniasis).

Ongoing regulatory amendments aim to strengthen diagnostic standards to ensure high-quality patient care. With the increasing prevalence of chronic and infectious diseases—such as diabetes, cardiovascular conditions, and various infectious diseases—the need for diagnostic laboratories continues to rise. Both private and public labs are undergoing accreditation to enhance service quality, expand testing volume, and strengthen patient trust. This expansion in laboratory infrastructure is expected to significantly increase global demand for IVD Quality Control (QC) products. Laboratories accredited by CLIA benefit from Medicare and Medicaid reimbursements, further supporting market growth.

Order a free sample PDF of the In Vitro Diagnostics Quality Control Market Intelligence Study, published by Grand View Research.

Key In Vitro Diagnostics Quality Control Company Insights

Prominent industry participants include Siemens Healthineers AG, Abbott, Bio-Rad Laboratories, and Danaher.

Siemens Healthineers AG provides extensive diagnostic, imaging, and therapy solutions, including medical accessories, OEM components, and healthcare IT. Its portfolio serves multiple clinical domains such as infectious diseases, cardiology, oncology, neurology, diabetes, and women’s health.

Abbott, operating across pharmaceuticals, medical devices, diagnostics, and nutritional products, maintains a presence in over 160 countries. It is a global leader in clinical diagnostics, covering clinical chemistry, hematology, and molecular diagnostics.

Key In Vitro Diagnostics Quality Control Companies

  • Siemens Healthineers AG
  • Abbott
  • Bio-Rad Laboratories
  • Danaher
  • Hoffmann-La Roche Ltd
  • Sysmex Corporation
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd
  • Helena Laboratories Corporation
  • Thermo Fisher Scientific Inc
  • SeraCare Life Sciences Inc
  • BD
  • Merck KGaA
  • QIAGEN
  • Hologic, Inc.
  • Bio-Techne
  • Fortress Diagnostics
  • Microbiologics
  • Trina Bio Reactive AG
  • Cone Bioproducts
  • Biorex Diagnostics

Conclusion

The in vitro diagnostics quality control market continues to grow steadily, driven by the expansion of certified laboratories, rising global disease burden, and increasing demand for reliable, high-quality diagnostic services. Advancements in regulatory standards, combined with growing test volumes and technological innovation, are further strengthening market adoption of QC products. As healthcare systems emphasize accuracy and reliability in diagnostics, the demand for robust IVD quality control solutions will keep accelerating across major regions, especially in rapidly expanding markets like Asia Pacific.

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.

Comments

Post a Comment

Popular posts from this blog

Urodynamic Equipment and Consumables Market Forecast: Anticipating Future Innovations

  The global urodynamic equipment and consumables market size is expected to reach USD 449.2 million in 2030 and is projected to grow at a CAGR of 5.7% from 2024 to 2030. This market is anticipated to grow at an unprecedented rate owing to growing geriatric population that exhibits greater vulnerability to urological dysfunctions. In addition, unprecedented upsurge in prevalence of bladder cancer poses high clinical urgency to adopt highly efficient diagnostics, which thereby broadens future growth prospects. In 2017, as per the American Cancer Society, bladder cancer accounted for 5.0% of all cancers in the U.S. The market is also driven by global increase in obesity. As per the Centers for Disease Control and Prevention, approximately 36.0% of adult population is obese. According to a research published in NCBI, obesity has increased the risk of developing various urological conditions, such as prostate cancer, nephrolithiasis, hypogonadism, and urinary tract infections. Furtherm...
Read more

Mobile Device Management Market Thrives with Growth in Cloud-Based Solutions

  According to a recent report by Grand View Research, Inc., the global   mobile device management (MDM) market   is projected to reach USD 28.37 billion by 2030, expanding at a CAGR of 24.5% from 2025 to 2030. This growth is primarily attributed to the increasing use of mobile devices in the workplace and the growing need to manage and secure them effectively. As smartphones, tablets, and other mobile devices become more prevalent, employees are increasingly using their personal devices for work—an approach known as Bring Your Own Device (BYOD). This trend is contributing to the rising number of mobile devices requiring centralized oversight and protection. MDM solutions offer organizations a unified platform to oversee and secure mobile devices, enabling functions such as security policy enforcement, device usage monitoring, and remote data wiping in cases of loss or theft. As companies continue to implement BYOD strategies or issue corporate devices to employees, deman...
Read more

U.S. Interventional Oncology Market Boosted by Aging Population

  The   U.S. interventional oncology market   size was estimated at USD 998.4 million in 2024 and is projected to reach USD 1,597 million by 2030, expanding at a CAGR of 8.17% from 2025 to 2030. This market growth is primarily driven by the increasing prevalence of cancer, continuous technological advancements in minimally invasive treatments, expanding investments in interventional oncology, and the aging population across the U.S. A major contributing factor is the rising incidence of cancer in the country. According to the American Cancer Society, approximately 2,041,910 new cancer cases are expected to be diagnosed in the U.S. in 2025, with 618,120 projected cancer-related deaths. As conventional therapies like chemotherapy and radiation often lead to significant side effects, minimally invasive techniques such as radiofrequency ablation and microwave ablation are becoming more popular. These procedures target tumors precisely while minimizing harm to surrounding tiss...
Read more